论文部分内容阅读
传统医药,特别是草药,在世界范围内日益受到人们的关注,使用也愈加广泛。可是,由于草药质量低下,有关草药出现的不良反应的报道也在增加。人们已经认识到要重视通过技术规范来提高药材原料的质量。从中国国家食品药品监督管理局以32号局令发布的《中华人民共和国中药材生产质量管理规范(试行)》、欧洲医药评价署在伦敦发布的《原药材种植和采集的生产质量管理规范细则》和日本厚生省认证的以“药用植物栽培和质量控制指南”为依据起草的《药用植物种植和生产质量管理规范》比较,三个规范都规定了相关药材种植生产。
Traditional medicines, especially herbal medicines, have drawn increasing attention and been used more and more widely in the world. However, due to the poor quality of herbs, there have also been reports of adverse reactions to herbs. It has been recognized that attention should be paid to improving the quality of medicinal ingredients through technical specifications. From the State Food and Drug Administration to the Order No. 32 issued by the “People’s Republic of China Chinese herbal medicine production quality management practices (for Trial Implementation)”, the European Medical Evaluation Agency in London released the “original cultivation and acquisition of raw materials, production quality management rules and regulations ”Compared with the“ Good Manufacturing Practice for Medicinal Plants ”drafted by Japan’s Ministry of Health, Labor and Welfare on the basis of“ Guidelines for Cultivation and Quality Control of Medicinal Plants ”, all three specifications stipulate the production of related medicinal plants.